We use cookies to understand how you use our site and to improve your experience. This includes personalizing content and advertising. To learn more, click here. By continuing to use our site, you accept our use of cookies, revised Privacy Policy and Terms of Service.
You are being directed to ZacksTrade, a division of LBMZ Securities and licensed broker-dealer. ZacksTrade and Zacks.com are separate companies. The web link between the two companies is not a solicitation or offer to invest in a particular security or type of security. ZacksTrade does not endorse or adopt any particular investment strategy, any analyst opinion/rating/report or any approach to evaluating individual securities.
If you wish to go to ZacksTrade, click OK. If you do not, click Cancel.
iRobot (IRBT) Enjoys Healthy Growth Drivers: Time to Buy?
Read MoreHide Full Article
We issued an updated research report on premium appliances company, iRobot Corporation (IRBT - Free Report) , on May 30.
Over the last three months, shares of this Zacks Rank #1 (Strong Buy) yielded a return of 67.25%, outperforming 6.22% growth recorded by the Zacks Industrial Automation and Robotics industry.
Notably, the attractiveness of this stock as a current investment choice is further accentuated by its favorable Growth Style Score ‘A’.
Reasons for the Solid Run
iRobot reported better-than-expected results in first-quarter 2017. Notably, the company raised its full-year earnings guidance to the $1.45–$1.70 per share range, as against the prior projection of $1.35–$1.65 per share. In addition, top-line guidance for the full-year 2017 has been increased to $780–$790 million range, as against the previous projection of $770–$785 million.
The company believes that sturdy demand for home robotic products, latest acquisitions and efficient marketing programs would drive its revenue growth trajectory in the upcoming quarters. Moreover, stronger top-line performance and greater operational efficacy are anticipated to enhance profitability, moving ahead.
Nevertheless, iRobot’s ongoing capital allocation program (initiated in 2016) is expected to boost the company’s financial fundamentals in the quarters ahead.
Over the last 30 days, the Zacks Consensus Estimate for the stock has been revised upward for both 2017 and 2018, reflecting positive market sentiments.
Other Key Picks
Some other top-ranked stocks in the industry are listed below:
Applied Industrial Technologies, Inc. (AIT - Free Report) , which sports a Zacks Rank #1 at present, pulled off an average positive earnings surprise of 9.78% over the last four quarters.
Acco Brands Corporation (ACCO - Free Report) currently carries a Zacks Rank #2 (Buy) and has an average positive earnings surprise of 79.74% for the past four quarters.
More Stock News: 8 Companies Verge on Apple-Like Run
Did you miss Apple's 9X stock explosion after they launched their iPhone in 2007? Now 2017 looks to be a pivotal year to get in on another emerging technology expected to rock the market. Demand could soar from almost nothing to $42 billion by 2025. Reports suggest it could save 10 million lives per decade which could in turn save $200 billion in U.S. healthcare costs.
A bonus Zacks Special Report names this breakthrough and the 8 best stocks to exploit it. Like Apple in 2007, these companies are already strong and coiling for potential mega-gains. Click to see them right now >>
See More Zacks Research for These Tickers
Normally $25 each - click below to receive one report FREE:
Image: Bigstock
iRobot (IRBT) Enjoys Healthy Growth Drivers: Time to Buy?
We issued an updated research report on premium appliances company, iRobot Corporation (IRBT - Free Report) , on May 30.
Over the last three months, shares of this Zacks Rank #1 (Strong Buy) yielded a return of 67.25%, outperforming 6.22% growth recorded by the Zacks Industrial Automation and Robotics industry.
Notably, the attractiveness of this stock as a current investment choice is further accentuated by its favorable Growth Style Score ‘A’.
Reasons for the Solid Run
iRobot reported better-than-expected results in first-quarter 2017. Notably, the company raised its full-year earnings guidance to the $1.45–$1.70 per share range, as against the prior projection of $1.35–$1.65 per share. In addition, top-line guidance for the full-year 2017 has been increased to $780–$790 million range, as against the previous projection of $770–$785 million.
The company believes that sturdy demand for home robotic products, latest acquisitions and efficient marketing programs would drive its revenue growth trajectory in the upcoming quarters. Moreover, stronger top-line performance and greater operational efficacy are anticipated to enhance profitability, moving ahead.
Nevertheless, iRobot’s ongoing capital allocation program (initiated in 2016) is expected to boost the company’s financial fundamentals in the quarters ahead.
Over the last 30 days, the Zacks Consensus Estimate for the stock has been revised upward for both 2017 and 2018, reflecting positive market sentiments.
Other Key Picks
Some other top-ranked stocks in the industry are listed below:
Caterpillar Inc (CAT - Free Report) delivered an average positive earnings surprise of 40.25% for the trailing four quarters and currently boasts a Zacks Rank #1. You can see the complete list of today’s Zacks #1 Rank stocks here.
Applied Industrial Technologies, Inc. (AIT - Free Report) , which sports a Zacks Rank #1 at present, pulled off an average positive earnings surprise of 9.78% over the last four quarters.
Acco Brands Corporation (ACCO - Free Report) currently carries a Zacks Rank #2 (Buy) and has an average positive earnings surprise of 79.74% for the past four quarters.
More Stock News: 8 Companies Verge on Apple-Like Run
Did you miss Apple's 9X stock explosion after they launched their iPhone in 2007? Now 2017 looks to be a pivotal year to get in on another emerging technology expected to rock the market. Demand could soar from almost nothing to $42 billion by 2025. Reports suggest it could save 10 million lives per decade which could in turn save $200 billion in U.S. healthcare costs.
A bonus Zacks Special Report names this breakthrough and the 8 best stocks to exploit it. Like Apple in 2007, these companies are already strong and coiling for potential mega-gains. Click to see them right now >>